Trane Technologies Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
Latest Ratings for TT Date Firm Action From To Feb 2022 Mizuho Maintains Neutral Feb 2022 Deutsche Bank Maintains Hold Feb 2022 Credit Suisse Maintains Outperform View More Analyst Ratings for TT View the Latest Analyst Ratings read more
Deep Dive Into Fiverr Intl Stock: Analyst Perspectives (6 Ratings)
Latest Ratings for FVRR Date Firm Action From To Feb 2022 RBC Capital Maintains Sector Perform Feb 2022 Needham Maintains Buy Jan 2022 Piper Sandler Initiates Coverage On Overweight View More Analyst Ratings for FVRR View the Latest Analyst Ratings read more
What Analysts Are Saying About Gilead Sciences Stock
Latest Ratings for GILD Date Firm Action From To Mar 2022 Barclays Maintains Underweight Mar 2022 RBC Capital Maintains Outperform Feb 2022 BMO Capital Downgrades Outperform Market Perform View More Analyst Ratings for GILD View the Latest Analyst Ratings read more
Where RenaissanceRe Holdings Stands With Analysts
Latest Ratings for RNR Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Nov 2021 Morgan Stanley Maintains Equal-Weight Nov 2021 Jefferies Initiates Coverage On Buy View More Analyst Ratings for RNR View the Latest Analyst Ratings read more
Adial Pharmaceuticals Highlights Favorable Comments From FDA Meeting For Lead Program In Alcohol Use Disorder
Adial Pharmaceuticals received FDA backing for its Phase 3 AD04 trial, including endpoints and strategies for targeted populations in Alcohol Use Disorder treatment. read more
Demystifying Chubb: Insights From 10 Analyst Reviews
Latest Ratings for CB Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Raymond James Maintains Strong Buy Jan 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for CB View the Latest Analyst Ratings read more